Tech Company Financing Transactions

ReviR Therapeutics Funding Round

Lapam Capital, 5Y Capital and CDH Investments participated in a $30 million Series A funding round for ReviR Therapeutics. The round was announced on 7/29/2024.

Transaction Overview

Company Name
Announced On
7/29/2024
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to further augment its AI-driven drug discovery VoyageR platform, which will be leveraged to advance proprietary chemical matter for novel and undruggable targets and to support clinical development of treatments for Huntington's disease (HD), Charcot-Marie-Tooth disease (CMT), amyotrophic lateral sclerosis (ALS), and other neurological disorders.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
150 North Hill Drive
Brisbane, CA 94005
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
ReviR Therapeutics is a research and development company whose mission is to harness advanced technologies, machine learning/AI, and the inherent biology embedded within RNA to develop novel medicines to treat human disease. Our AI-based platform allows us to expand beyond the protein-based target space to reach a large number of known disease targets previously considered "undruggable"
Profile
ReviR Therapeutics LinkedIn Company Profile
Social Media
ReviR Therapeutics Company Twitter Account
Company News
ReviR Therapeutics News
Facebook
ReviR Therapeutics on Facebook
YouTube
ReviR Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Peng Yue
  Peng Yue LinkedIn Profile  Peng Yue Twitter Account  Peng Yue News  Peng Yue on Facebook
Chief Scientific Officer
Paul August
  Paul August LinkedIn Profile  Paul August Twitter Account  Paul August News  Paul August on Facebook
Vice President
Yang Liu
  Yang Liu LinkedIn Profile  Yang Liu Twitter Account  Yang Liu News  Yang Liu on Facebook
Vice President
Sridhar Narayan
  Sridhar Narayan LinkedIn Profile  Sridhar Narayan Twitter Account  Sridhar Narayan News  Sridhar Narayan on Facebook
VP - Bus. Development
Sarah Burnett
  Sarah Burnett LinkedIn Profile  Sarah Burnett Twitter Account  Sarah Burnett News  Sarah Burnett on Facebook
VP - R & D
Steve Lianoglou
  Steve Lianoglou LinkedIn Profile  Steve Lianoglou Twitter Account  Steve Lianoglou News  Steve Lianoglou on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/29/2024: Helpt venture capital transaction
Next: 7/29/2024: Hive Health venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary